Novel gene editing technique reveals cancer weakness in the immune system and opens possibilities to identify disease-causing genes and new drug targets
Scientists at Mount Sinai have developed a novel technology for simultaneously analyzing the functions of hundreds of genes with resolution reaching the single cell level. The technology relies on a barcoding approach using a novel protein described in a paper published in the journal Cell.
Since the sequencing of the first human genome in the early 2000s revealed a set of more than 20,000 protein-coding genes, scientists have not yet been able to characterize the many functions of individual gene. Without that information, our understanding of how the human genome works — and how to use that knowledge to predict, prevent, treat and even cure disease — is limited. In 2012 and 2013, scientists established a powerful new approach for editing genes, called CRISPR, which can be used to determine gene functions. CRISPR has taken the scientific world by storm, but researchers have still been challenged with using CRISPR to study the many thousands of genes and their numerous possible roles.
A new technology developed by scientists at the Icahn School of Medicine at Mount Sinai helps address the genomics challenge of analyzing the genome at an unprecedented scale. The research, led by postdoctoral fellows Aleksandra Wroblewska, PhD and Maxime Dhainaut, PhD, is novel tool to barcode and track different CRISPRs using synthetic proteins called epitopes. The protein barcodes referred to as Pro-codes, enables hundreds of CRISPRs to be used together to knockout a multitude of genes.
While there are existing technologies for pooling CRISPRs, these approaches rely heavily on DNA as a barcode and permit only a low resolution look into gene function. Through the Pro-Code technique, Mount Sinai researchers were able to demonstrate a way for scientists to more comprehensively characterize the biological effects of a gene.,
In the study, the researchers used the Pro-Code technology to search for genes required for the immune system to protect from cancer. They generated CRISPRs to target the deletion of suspected immune regulatory genes, and paired them with the Pro-Codes. Pro-Code/CRISPR libraries were then introduced to breast cancer cells, and the tumors were challenged with killer T cells that had been engineered to recognize the cancer cells. Most of the cancer cells were rapidly eliminated by the T cells but there were some cells that completed resisted death. The Pro-Code technology helped determine which genes were lost in the resistant cells some with unrecognized roles in sensitizing cancer cells in the immune system. The studies also identified a negative regulator of the immune checkpoint PD-L1, a major clinical target of cancer immunotherapy.
“There is still a great deal of work to be done to fully understand the human genome. We still don’t know what most genes do and how they are connected,” said Brian Brown, PhD, Associate Professor of Genetics and Genomic Sciences and Associate Director of the Immunology Institute at the Icahn Institute at Mount Sinai and senior author of the publication. “The Pro-Code technology could greatly accelerate one of the major goals of the post-genome era: annotation of the human genome. This discovery will be key to discover disease-causing genes that could lead to novel drug targets. It’s already given us new insights in cancer immunology.”
Learn more: Scientists Identify Critical Cancer Immunity Genes Using New Genetic Barcoding Technology
The Latest on: Genetic barcoding
[google_news title=”” keyword=”genetic barcoding” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Genetic barcoding
- Best DNA Test for 2024on May 3, 2024 at 4:01 am
CNET’s expert staff reviews and rates dozens of new products and services each month, building on more than a quarter century of expertise. Open up even more of your world with the best at-home ...
- Healthy lifestyle may offset genetics by 60% and add five years to life, study sayson April 30, 2024 at 3:32 am
Genetics alone can mean a 21% greater risk of early death, research finds, but people can improve their chances A healthy lifestyle may offset the impact of genetics by more than 60% and add ...
- Genetic analysis reveals H5N1 flu virus outbreak in cows likely started earlier than thoughton April 22, 2024 at 4:59 pm
The genetic data point to a single spillover event that probably occurred in late 2023, Michael Worobey, an evolutionary virologist at the University of Arizona, told STAT on Tuesday.
- Thanks to a genetic breakthrough, a rare rhino species may be rescued from extinctionon April 15, 2024 at 10:30 pm
Since more and more species are dying, it creates an increasing number of genetic bottlenecks, which make animal and plant survival even more difficult. Take for example the white rhinoceros ...
- News tagged with genetic materialon April 15, 2024 at 5:00 pm
Bacteriophages, or phages for short, are viruses that infect bacteria and kill them through a lysis process. Phages can kill bacteria on or in a multicellular host organism, such as the polyp of ...
- Genetic Testing Insurance Coverage Trendson April 15, 2024 at 5:00 pm
Of the 66 insurers that had publicly viewable medical policies, 65 (98%) included at least one policy addressing genetic testing. These insurers had an average of 13 distinct policy documents ...
- From a cryptic genetic element in the human gut to a sensitive biomarkeron April 15, 2024 at 5:00 pm
Plasmids are small extrachromosomal genetic elements that frequently occur in bacterial cells and can influence microbial lifestyles – yet their diversity in natural habitats is poorly understood.
- A study looking at carboplatin in prostate cancer with genetic changes (BARCODE 2)on April 8, 2024 at 5:00 pm
Doctors think certain chemotherapy drugs might work better in people with certain genetic changes. There are 2 parts in this study. Part 1 involves testing for gene changes (mutations). You have a ...
- Genetic analysis reveals true origin of chronic kidney disease in undiagnosed patientson April 2, 2024 at 4:59 pm
Researchers conducted a comprehensive genetic analysis of end-stage renal failure patients with chronic kidney disease of unknown cause. They found that more than 10% of these patients had disease ...
via Bing News